T1	PROC 46 95	Estudio abierto y de una sola rama de tratamiento
T2	CHEM 139 146	ABT-493
#1	AnnotatorNotes T2	C4310002; ABT-493; Organic Chemical · Pharmacologic Substance
T3	PROC 101 135	evaluar la eficacia y la seguridad
#2	AnnotatorNotes T3	C0511730; Identify product efficacy and safety issues; Health Care Activity
T4	DISO 170 218	infección crónica por el virus de la hepatitis C
#3	AnnotatorNotes T4	C4708423; Chronic hepatitis C caused by hepatitis C virus genotype 6; Disease or Syndrome +  C4708424; Chronic hepatitis C caused by hepatitis C virus genotype 5; Disease or Syndrome + C4708469; Chronic hepatitis C caused by Hepatitis C virus genotype 4; Disease or Syndrome 
T5	PROC 260 309	Estudio abierto y de una sola rama de tratamiento
T6	CHEM 353 360	ABT-493
#4	AnnotatorNotes T6	C4310002; ABT-493; Organic Chemical · Pharmacologic Substance
T7	PROC 315 349	evaluar la eficacia y la seguridad
#5	AnnotatorNotes T7	C0511730; Identify product efficacy and safety issues; Health Care Activity
T8	CHEM 361 368	ABT-530
#6	AnnotatorNotes T8	C4310001; ABT-530; Organic Chemical · Pharmacologic Substance
T9	DISO 489 518	Infección crónica Hepatitis C
T10	DISO 1605 1608	VHC
#7	AnnotatorNotes T10	C0019196; Hepatitis C; Disease or Syndrome
T11	DISO 545 593	Infección crónica por el virus de la hepatitis C
#8	AnnotatorNotes T11	C4708423; Chronic hepatitis C caused by hepatitis C virus genotype 6; Disease or Syndrome +  C4708424; Chronic hepatitis C caused by hepatitis C virus genotype 5; Disease or Syndrome + C4708469; Chronic hepatitis C caused by Hepatitis C virus genotype 4; Disease or Syndrome 
T12	CHEM 880 883	AAD
#9	AnnotatorNotes T12	C3653501; DIRECT ACTING ANTIVIRALS; Pharmacologic Substance
T13	DISO 764 781	infección por VHC
T14	DISO 797 822	Infección crónica por VHC
T15	PROC 868 879	tratamiento
#10	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	DISO 1745 1757	sensibilidad
T17	PROC 973 982	protocolo
#11	AnnotatorNotes T17	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T18	DISO 1238 1277	abuso en el consumo de drogas y alcohol
T19	CHEM 1324 1342	fármaco en estudio
#12	AnnotatorNotes T19	C0013230; Investigational New Drugs; Pharmacologic Substance
T20	PROC 1380 1389	protocolo
#13	AnnotatorNotes T20	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T21	PROC 1515 1520	AgHBs
#14	AnnotatorNotes T21	C0201477; Hepatitis B surface antigen measurement; Laboratory Procedure
T22	PROC 1524 1582	anticuerpos frente al virus de la inmunodeficiencia humana
#15	AnnotatorNotes T22	C3714540; HIV Antibody Measurement; Laboratory Procedure
T23	PROC 1584 1590	Ac VIH
T24	DISO 1686 1689	VHC
#16	AnnotatorNotes T24	C0019196; Hepatitis C; Disease or Syndrome
T25	CHEM 1783 1793	excipiente
#17	AnnotatorNotes T25	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T26	CHEM 1801 1809	fármacos
#18	AnnotatorNotes T26	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T27	CHEM 147 154	ABT-530
#19	AnnotatorNotes T27	C4310001; ABT-530; Organic Chemical · Pharmacologic Substance
T28	DISO 384 432	infección crónica por el virus de la hepatitis C
#20	AnnotatorNotes T28	C4708423; Chronic hepatitis C caused by hepatitis C virus genotype 6; Disease or Syndrome +  C4708424; Chronic hepatitis C caused by hepatitis C virus genotype 5; Disease or Syndrome + C4708469; Chronic hepatitis C caused by Hepatitis C virus genotype 4; Disease or Syndrome 
T29	DISO 893 896	VHC
#21	AnnotatorNotes T29	C0019196; Hepatitis C; Disease or Syndrome
T30	DISO 941 951	cirróticos
#22	AnnotatorNotes T30	C1623038; Cirrhosis; Disease or Syndrome
T31	PROC 1305 1319	administración
#23	AnnotatorNotes T31	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T32	PROC 1476 1513	antígeno de superficie de hepatitis B
#24	AnnotatorNotes T32	C0201477; Hepatitis B surface antigen measurement; Laboratory Procedure
T33	DISO 1647 1659	co-infección
T34	Date 13 17	2015
T35	LIVB 158 165	adultos
#25	AnnotatorNotes T35	C0001675; Adult; Age Group
T36	Duration 180 187	crónica
#26	AnnotatorNotes T36	C0205191; chronic; Temporal Concept
T37	LIVB 195 218	virus de la hepatitis C
#27	AnnotatorNotes T37	C0220847; hepatitis C virus; Virus
T38	PROC 219 228	genotipos
#28	AnnotatorNotes T38	C1285573; Genotype determination; Laboratory Procedure
T39	LIVB 372 379	adultos
#29	AnnotatorNotes T39	C0001675; Adult; Age Group
T40	Duration 394 401	crónica
#30	AnnotatorNotes T40	C0205191; chronic; Temporal Concept
T41	LIVB 409 432	virus de la hepatitis C
#31	AnnotatorNotes T41	C0220847; hepatitis C virus; Virus
T42	PROC 433 442	genotipos
#32	AnnotatorNotes T42	C1285573; Genotype determination; Laboratory Procedure
T43	Duration 499 506	crónica
#33	AnnotatorNotes T43	C0205191; chronic; Temporal Concept
T44	Duration 555 562	crónica
#34	AnnotatorNotes T44	C0205191; chronic; Temporal Concept
T45	LIVB 570 593	virus de la hepatitis C
#35	AnnotatorNotes T45	C0220847; hepatitis C virus; Virus
T46	PROC 594 603	genotipos
#36	AnnotatorNotes T46	C1285573; Genotype determination; Laboratory Procedure
T47	LIVB 641 648	Hombres
#37	AnnotatorNotes T47	C0025266; Male population group; Population Group
T48	LIVB 651 658	mujeres
#38	AnnotatorNotes T48	C0043210; Woman; Population Group
T49	Age 659 677	mayores de 18 años
T50	LIVB 778 781	VHC
#39	AnnotatorNotes T50	C0220847; hepatitis C virus; Virus
T51	Duration 807 814	crónica
#40	AnnotatorNotes T51	C0205191; chronic; Temporal Concept
T52	LIVB 819 822	VHC
#41	AnnotatorNotes T52	C0220847; hepatitis C virus; Virus
T53	LIVB 830 838	paciente
#42	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T55	Neg_cue 862 867	nunca
T57	LIVB 905 914	pacientes
#43	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	Neg_cue 938 940	no
T59	LIVB 1013 1029	Mujer embarazada
#44	AnnotatorNotes T59	C0033011; Pregnant Women; Population Group
T60	PHYS 1085 1096	amamantando
#45	AnnotatorNotes T60	C0006147; Breast Feeding; Organism Function
T61	LIVB 1099 1106	hombres
#46	AnnotatorNotes T61	C0025266; Male population group; Population Group
T62	LIVB 1115 1121	pareja
#47	AnnotatorNotes T62	C0682323; Partner in relationship; Family Group
T63	LIVB 1125 1144	mujeres embarazadas
#48	AnnotatorNotes T63	C0033011; Pregnant Women; Population Group
T64	LIVB 1203 1211	Paciente
#49	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T65	Date 1226 1234	reciente
T66	Duration 1285 1292	6 meses
T69	LIVB 1399 1411	investigador
#50	AnnotatorNotes T69	C0035173; Research Personnel; Professional or Occupational Group
T70	LIVB 1546 1582	virus de la inmunodeficiencia humana
#51	AnnotatorNotes T70	C0019682; HIV; Virus
T71	LIVB 1587 1590	VIH
#52	AnnotatorNotes T71	C0019682; HIV; Virus
T72	PROC 1596 1604	Genotipo
#53	AnnotatorNotes T72	C1285573; Genotype determination; Laboratory Procedure
T74	PROC 1674 1682	genotipo
#54	AnnotatorNotes T74	C1285573; Genotype determination; Laboratory Procedure
T77	PHYS 1052 1062	embarazada
#55	AnnotatorNotes T77	C0032961; Pregnancy; Organism Function
T78	PHYS 1168 1179	embarazadas
#56	AnnotatorNotes T78	C0032961; Pregnancy; Organism Function
T54	PHYS 1019 1029	embarazada
#57	AnnotatorNotes T54	C0032961; Pregnancy; Organism Function
T56	PHYS 1133 1144	embarazadas
#58	AnnotatorNotes T56	C0032961; Pregnancy; Organism Function
T79	CHEM 1261 1267	drogas
#59	AnnotatorNotes T79	C0086190; Illicit Drugs; Hazardous or Poisonous Substance
A1	Assertion T15 Negated
A2	Assertion T12 Negated
A3	Assertion T30 Negated
A4	Population_data T35 Age
A5	Population_data T39 Age
A6	Status T15 History_of
A7	Status T12 History_of
A8	Status T18 History_of
A9	Status T79 History_of
A10	Status T16 History_of
#60	AnnotatorNotes T9	C4708423; Chronic hepatitis C caused by hepatitis C virus genotype 6; Disease or Syndrome +  C4708424; Chronic hepatitis C caused by hepatitis C virus genotype 5; Disease or Syndrome + C4708469; Chronic hepatitis C caused by Hepatitis C virus genotype 4; Disease or Syndrome 
#61	AnnotatorNotes T14	C0524910; Hepatitis C, Chronic; Disease or Syndrome
#62	AnnotatorNotes T13	C0019196; Hepatitis C; Disease or Syndrome
#63	AnnotatorNotes T18	C0085762; Alcohol abuse; Mental or Behavioral Dysfunction + C0013146; Drug abuse; Mental or Behavioral Dysfunction
#64	AnnotatorNotes T23	C3714540; HIV Antibody Measurement; Laboratory Procedure
#65	AnnotatorNotes T33	C0275524; Coinfection; Disease or Syndrome
#66	AnnotatorNotes T16	C0020517; Hypersensitivity; Pathologic Function
T67	Neg_cue 1355 1362	impedir
T68	Observation 1366 1389	adherencia al protocolo
A11	Assertion T68 Negated
R1	Negation Arg1:T67 Arg2:T68	
T73	Food 1270 1277	alcohol
#67	AnnotatorNotes T73	C0001967; Alcoholic Beverages; Food
R2	Combined_with Arg1:T2 Arg2:T27	
R3	Experiences Arg1:T35 Arg2:T2	
R4	Experiences Arg1:T35 Arg2:T4	
R5	Causes Arg1:T37 Arg2:T4	
R6	Has_Duration_or_Interval Arg1:T4 Arg2:T36	
R7	Experiences Arg1:T35 Arg2:T38	
T75	Quantifier_or_Qualifier 219 237	genotipos 4, 5 o 6
R8	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T75	
T76	Quantifier_or_Qualifier 433 451	genotipos 4, 5 o 6
R9	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T76	
R10	Causes Arg1:T41 Arg2:T28	
R11	Has_Duration_or_Interval Arg1:T28 Arg2:T40	
R12	Experiences Arg1:T39 Arg2:T6	
R13	Experiences Arg1:T39 Arg2:T28	
R14	Experiences Arg1:T39 Arg2:T42	
R15	Combined_with Arg1:T6 Arg2:T8	
R16	Has_Duration_or_Interval Arg1:T9 Arg2:T43	
R17	Causes Arg1:T45 Arg2:T11	
R18	Has_Duration_or_Interval Arg1:T11 Arg2:T44	
T80	Quantifier_or_Qualifier 594 611	genotipos 4,5 o 6
R19	Has_Quantifier_or_Qualifier Arg1:T45 Arg2:T80	
T81	Quantifier_or_Qualifier 782 792	GT4, 5 o 6
R20	Has_Quantifier_or_Qualifier Arg1:T50 Arg2:T81	
R21	Causes Arg1:T50 Arg2:T13	
R22	Has_Age Arg1:T47 Arg2:T49	
R23	Has_Age Arg1:T48 Arg2:T49	
T82	PROC 698 707	selección
#68	AnnotatorNotes T82	C0242802; Patient Selection; Research Activity
R24	Overlap Arg1:T82 Arg2:T49	
T83	PROC 744 753	selección
#69	AnnotatorNotes T83	C0242802; Patient Selection; Research Activity
R25	Overlap Arg1:T83 Arg2:T13	
R26	Has_Duration_or_Interval Arg1:T14 Arg2:T51	
R27	Causes Arg1:T52 Arg2:T14	
R28	Experiences Arg1:T53 Arg2:T15	
R29	Experiences Arg1:T53 Arg2:T29	
R30	Used_for Arg1:T12 Arg2:T15	
R31	Negation Arg1:T55 Arg2:T15	
R32	Negation Arg1:T55 Arg2:T12	
R33	Experiences Arg1:T57 Arg2:T30	
R34	Negation Arg1:T58 Arg2:T30	
R35	Experiences Arg1:T59 Arg2:T54	
T84	Observation 1036 1062	planee quedarse embarazada
#70	AnnotatorNotes T84	C0032992; Pregnancy, Planned; Finding
R36	Before Arg1:T84 Arg2:T77	
T85	PROC 1074 1081	estudio
#71	AnnotatorNotes T85	C0008976; Clinical Trials; Research Activity
R37	Overlap Arg1:T54 Arg2:T85	
R38	Overlap Arg1:T84 Arg2:T85	
R39	Overlap Arg1:T77 Arg2:T85	
R40	Overlap Arg1:T85 Arg2:T60	
R41	Experiences Arg1:T63 Arg2:T56	
R42	Overlap Arg1:T85 Arg2:T56	
T86	Observation 1151 1179	planeen quedarse embarazadas
T87	PROC 1191 1198	estudio
#72	AnnotatorNotes T87	C0008976; Clinical Trials; Research Activity
R43	Overlap Arg1:T86 Arg2:T87	
R44	Overlap Arg1:T78 Arg2:T87	
R45	Before Arg1:T86 Arg2:T78	
#73	AnnotatorNotes T86	C0032992; Pregnancy, Planned; Finding
R46	Overlap Arg1:T54 Arg2:T87	
R47	Overlap Arg1:T77 Arg2:T87	
R48	Overlap Arg1:T84 Arg2:T87	
R49	Overlap Arg1:T60 Arg2:T87	
R50	Overlap Arg1:T56 Arg2:T87	
R51	Overlap Arg1:T85 Arg2:T86	
R52	Overlap Arg1:T85 Arg2:T78	
R53	Overlap Arg1:T18 Arg2:T65	
R54	Causes Arg1:T79 Arg2:T18	
R55	Causes Arg1:T73 Arg2:T18	
R56	Experiences Arg1:T64 Arg2:T18	
R57	Experiences Arg1:T64 Arg2:T31	
R58	Before Arg1:T18 Arg2:T31	
R59	Overlap Arg1:T18 Arg2:T66	
R60	Used_for Arg1:T19 Arg2:T31	
R61	Before Arg1:T18 Arg2:T68	
#74	AnnotatorNotes T68	C2364172; Adherence To Medication Regime; Finding (?)
R62	Experiences Arg1:T64 Arg2:T79	
R63	Experiences Arg1:T64 Arg2:T73	
T88	Result_or_Value 1416 1451	Resultados de laboratorio positivos
#75	AnnotatorNotes T88	C1948092; positive screening/culture/laboratory results; Finding
R64	Has_Result_or_Value Arg1:T32 Arg2:T88	
R65	Has_Result_or_Value Arg1:T21 Arg2:T88	
R66	Has_Result_or_Value Arg1:T22 Arg2:T88	
R67	Has_Result_or_Value Arg1:T23 Arg2:T88	
R68	Causes Arg1:T70 Arg2:T88	
R69	Causes Arg1:T71 Arg2:T88	
T89	PROC 1625 1634	selección
#76	AnnotatorNotes T89	C0242802; Patient Selection; Research Activity
T90	PROC 1458 1467	selección
#77	AnnotatorNotes T90	C0242802; Patient Selection; Research Activity
R70	Overlap Arg1:T88 Arg2:T90	
R71	Overlap Arg1:T90 Arg2:T32	
R72	Overlap Arg1:T90 Arg2:T21	
R73	Overlap Arg1:T90 Arg2:T22	
R74	Overlap Arg1:T90 Arg2:T23	
R75	Overlap Arg1:T72 Arg2:T89	
R76	Overlap Arg1:T10 Arg2:T33	
R77	Overlap Arg1:T72 Arg2:T33	
R78	Overlap Arg1:T33 Arg2:T74	
T91	Quantifier_or_Qualifier 1664 1682	más de un genotipo
R79	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T91	
R80	Overlap Arg1:T33 Arg2:T24	
R81	Overlap Arg1:T89 Arg2:T74	
R82	Overlap Arg1:T10 Arg2:T89	
R83	Overlap Arg1:T89 Arg2:T33	
R84	Overlap Arg1:T89 Arg2:T24	
R85	Causes Arg1:T25 Arg2:T16	
R86	Causes Arg1:T26 Arg2:T16	
T92	Quantifier_or_Qualifier 1707 1715	gravedad
#78	AnnotatorNotes T92	C1547227; Severe -Severity of Illness Code; Intellectual Product
R87	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T92	
A12	Status T92 History_of
T93	Observation 1717 1737	amenaza para la vida
#79	AnnotatorNotes T93	C2826244; Life Threatening; Finding
R88	Causes Arg1:T25 Arg2:T93	
R89	Causes Arg1:T26 Arg2:T93	
R90	Overlap Arg1:T79 Arg2:T65	
#80	AnnotatorNotes T65	C0332185; Recent; Temporal Concept
A13	Experiencer T47 Patient
A14	Experiencer T48 Patient
A15	Experiencer T53 Patient
A16	Experiencer T57 Patient
A17	Experiencer T59 Patient
A18	Status T77 Future
A19	Experiencer T61 Patient
A20	Experiencer T62 Family_member
A21	Experiencer T63 Patient
A22	Status T78 Future
A23	Experiencer T64 Patient
A24	Experiencer T69 Other
